2024 VEITHsymposium - Session Detail

Tuesday, November 19 - Saturday, November 23, 2024

My countdown
Tuesday, November 19, 2024
SESSION 8: MORE NEW DEVELOPMENTS REGARDING TBADS AND TEVAR: NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TYPE B AORTIC DISSECTION (UTBADS) (FOR IMPORTANT RELATED TALKS SEE SESSION 8 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHSYMPOSIUM.ORG)
Location: Grand Ballroom East, 3rd Floor
Moderators: Jon S. Matsumura, MD / William D. Jordan Jr., MD / Jean M. Panneton, MD  
SESSION 8 SCHEDULE
4:56 PM - 5:01 PM
DEBATE ROUND 2 (Updated From 2023): With Uncomplicated TBADs, The Case For Early TEVAR With Extensive Aortic Coverage In Most Patients: New Data

Presenter(s): William D. Jordan Jr., MD  
Location: Grand Ballroom East, 3rd Floor

5:02 PM - 5:07 PM
DEBATE ROUND 2 (Updated From 2023): With Uncomplicated Acute TBADs, The Case For Waiting 2-6 Weeks From Onset For TEVAR And Then Limiting Aortic Coverage: New Data

Presenter(s): Mark A. Farber, MD  
Location: Grand Ballroom East, 3rd Floor

DO WE NEED AN RCT COMPARING TEVAR VERSUS MEDICAL TREATMENT FOR uTBADs
5:08 PM - 5:13 PM
Fate Of Medically Managed Acute TBADs: A Plea For Early Repair In Most Patients-Including Those Who Appear Uncomplicated

Presenter(s): Fabio Verzini, MD, PhD, FEBVS  
Location: Grand Ballroom East, 3rd Floor

5:14 PM - 5:19 PM
TEVAR For Acute TBAD Significantly Reduces All-Cause Mortality At 3-Years Compared To Best Medical Management: New Data On Outcomes Of All Dissections In England: We Really Don't Need A Randomized Trial

Presenter(s): Jonathan R. Boyle, MD, MA (Cantab) FRCS  
Location: Grand Ballroom East, 3rd Floor

5:20 PM - 5:25 PM
TEVAR To Treat Uncomplicated Acute/Subacute Type B Aortic Dissections (uTBADs) Must Still Be Justified By An RCT: Is An Appropriate One Possible Or Not

Presenter(s): Colin D. Bicknell, MD, FRCS  
Location: Grand Ballroom East, 3rd Floor

5:26 PM - 5:31 PM
Scandinavian (SUNDAY) RCT Comparing TEVAR Versus Medical Therapy In uTBAD: Justification, Rationale And Current Status

Presenter(s): Jacob Budtz-Lilly, MD, PhD  
Location: Grand Ballroom East, 3rd Floor

5:32 PM - 5:37 PM
Status Of The Multicenter RCT (IMPROVE-AD) To Evaluate The Value Of TEVAR Versus Medical Therapy In Acute And Subacute uTBADs: Rationale And Recruitment To Date

Presenter(s): Firas F. Mussa, MD / Panos Kougias, MD, MSc  
Location: Grand Ballroom East, 3rd Floor

5:38 PM - 5:43 PM
Advances In The Endovascular Repair Of Complex Aortic Dissections: Timing Of Interventions, Adjunctive Techniques And Outcomes

Presenter(s): Rami Tadros, MD  
Location: Grand Ballroom East, 3rd Floor

5:44 PM - 5:49 PM
What Does Endovascular Aortic Repair Do To Cardiac And Coronary Artery Function: Does The Position Of The Graft In The Aorta Make A Difference: Do We Need A Compliant Endograft

Presenter(s): Rachel E. Clough, PhD, FRCS  
Location: Grand Ballroom East, 3rd Floor

5:50 PM - 5:55 PM
Re-Entry Specific Endovascular Therapy (RESET), i.e. TEVAR Plus Dealing With Re-Entry Tears: It Promotes False Lumen Thrombosis, Aortic Remodeling And Improves Outcomes: How To Do It

Presenter(s): Jean M. Panneton, MD  
Location: Grand Ballroom East, 3rd Floor

5:56 PM - 6:02 PM
Panel Discussion
End of Program A